Manchester Financial’s Genmab GMAB Stock Holding History

Manchester Financial’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-345	Closed	-$8K	–	533
2019 Q4	$8K	Buy	+345	New	+$7.53K	﹤0.01%	372

Other funds holding GMAB

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Manchester Financial's GMAB Position: Q1 2020 in Review

Manchester Financial sold out of Genmab (GMAB) in Q1 2020, closing a stake of 345 shares — an estimated $8K sold.

Manchester Financial first reported a position in GMAB in Q4 2019 and held it in 1 quarter. The position peaked at $8K in Q4 2019. 142 funds tracked by Wall St. Rank hold GMAB as of Q1 2020.

Manchester Financial reported no remaining Genmab position as of Q1 2020 after selling out during the quarter.
Manchester Financial sold 345 Genmab shares in Q1 2020, an estimated $8K.
Manchester Financial first reported a position in Genmab in Q4 2019 and held it in 1 quarter.
Manchester Financial's Genmab position peaked at $8K in Q4 2019.
142 funds tracked by Wall St. Rank held Genmab as of Q1 2020.

Based on Manchester Financial's 13F filing for Q1 2020, filed 20 Apr 2020.